Eli Lilly Says HHS Ignores Drug Discount Double-Dipping

By Lauren Berg · November 15, 2024, 11:25 PM EST

Eli Lilly & Co. claims the U.S. Department of Health and Human Services is unlawfully blocking its efforts to crack down on hospitals the company alleges are double-dipping on medication discounts...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

ELI LILLY AND COMPANY et al v. XAVIER BECERRA et al

Case Number

Court

District Of Columbia

Nature of Suit

Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

November 14, 2024

Recent Articles By Lauren

November 12, 2024
J&J Says HHS Is Thwarting Transparency Of Drug Discounts
October 30, 2024
FDA Didn't Flub Approval In Orphan Drug Case, DC Court Says
October 18, 2024
Oklahoma Brings Title X Funding Cut Fight To Justices
October 11, 2024
Feds Target Ill. Hospital CEO As $19M Theft Probe Widens
October 11, 2024
Quinn Emanuel Gets Trimmed $92M Fee In ACA Cases
September 30, 2024
Takeda End Payors, Direct Buyers Win Antitrust Class Cert.
September 30, 2024
Bristol-Myers Beats Celgene Investors' Drug Delay Suit
September 27, 2024
9th Circ. Says Stem Cell Treatment Not Exempt From FDA Rule
August 30, 2024
McKesson, Others To Pay Benefit Plans $300M In Opioid Deal
August 23, 2024
NY Can't Sue Groups Over Abortion 'Reversal' Ads, For Now